RM52 70 mg Pill - blue & orange capsule/oblong, 18mm
Pill with imprint RM52 70 mg is Blue & Orange, Capsule/Oblong and has been identified as Lisdexamfetamine Dimesylate 70 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Lisdexamfetamine is used in the treatment of Binge Eating Disorder; ADHD and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Lisdexamfetamine 70 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for RM52 70 mg
Lisdexamfetamine Dimesylate
- Imprint
- RM52 70 mg
- Strength
- 70 mg
- Color
- Blue & Orange
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 57664-0052
See also:
Vyvanse
Vyvanse is a prescription stimulant used to treat ADHD in children and adults, and binge eating ...
Arynta
Arynta is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults and children 6 ...
Xywav
Xywav is used for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients ...
Adderall
Adderall (amphetamine and dextroamphetamine) is used to treat narcolepsy and ADHD. Includes side ...
Adipex-P
Adipex-P (phentermine) is an appetite suppressant used togther with diet and exercise to treat ...
More about lisdexamfetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,091)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
- Lisdexamfetamine Dimesylate monograph
- Lisdexamfetamine Dimesylate Capsules (FDA)
- Lisdexamfetamine Dimesylate Chewable Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.